Caricamento...
Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder
BACKGROUND: This open trial was conducted to evaluate the effectiveness of intravenous clomipramine (CMI) in refractory obsessive-compulsive disorder (OCD). METHODS: Thirty OCD poor responders to previous multiple trials of anti-obsessive medications were selected and admitted to the hospital. Sever...
Salvato in:
| Pubblicato in: | Int J Neuropsychopharmacol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772819/ https://ncbi.nlm.nih.gov/pubmed/26221004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv084 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|